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Abstract
Probiotics are “living microorganisms” which exert a prophylactic and therapeutic ef‐
fect by improving the internal microbial balance. Probiotics play a role in defining and
maintaining the delicate balance between necessary and excessive defence mecha‐
nisms including innate and adaptive immune responses. The beneficial effects of pro‐
biotics have been demonstrated in many diseases.
New therapeutic approaches toward several inflammatory diseases are being devel‐
oped by affecting the microbial composition of the gut immune system. They are
based on the fact that this part of immune system is influenced by many factors, in‐
cluding dietary components and commensal bacteria. An understanding of the molec‐
ular mechanisms behind the direct and indirect effects on the gut immune response
will facilitate better and possibly more efficient therapy for diseases, although probi‐
otics (live microorganisms) have already shown promise as treatments for several dis‐
eases in both clinical and animal studies.
Further, the concept of probiotics and the direct and indirect mechanisms by which
they can influence gut immunity are described. Emphasis will be placed on the rela‐
tionship of microbiota and the gut immune system.
A review of the history of Lactobacillus bulgaricus, probiotics, and probiotic functional
foods is made and legislation and modern challenges are discussed.
Keywords: Probiotics, immunity, probiotic genomic, history, legislation
1. Introduction
Probiotics are defined by the World Health Organization as "live microorganisms, which when
administered in adequate amounts, confer a health benefit upon the host." The main benefit
of probiotics is that they help restore balance in the intestinal microbiota. Probiotics play a role
in defining and maintaining the delicate balance between necessary and excessive defence
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mechanisms including innate and adaptive immune responses. The immunological mecha‐
nisms supporting probiotics and prebiotics effects continue to be better defined with novel
mechanisms being described for dendritic cells, epithelial cells, T regulatory cells, effector
lymphocytes, natural killer T cells, and B cells [1].
Looking to probiotics to support immune health is nothing new; the idea has existed for more
than 100 years [2]. For millennia, humans have consumed microorganisms via fermented
foods. Human beings and gut microbiota are in a symbiotic relationship, and the hypothesis
of a “super organism” composed of the human organism and microbes has been recently
proposed. The gut microbiota performs important metabolic and immunological tasks, and
the impairment of its composition might alter homeostasis and lead to the development of
microbiota-related diseases [3].
The most common illnesses associated with alterations of the gut microbiota include inflam‐
matory bowel disease, gastrointestinal infections, irritable bowel syndrome and other gastro‐
intestinal functional diseases, colorectal cancer, metabolic syndrome and obesity, liver
disorders, allergy, and neurological diseases [4,5].
Neural pathways and central nervous system (CNS) signalling systems, according to new
studies, can be activated by bacteria in the gastrointestinal (GI) tract, including commensal,
probiotic, and pathogenic bacteria. Novel approaches for prevention and treatment of mental
illness, including anxiety and depression [6], may be provided by actual and future animal
and clinical studies, aimed at understanding the microbiota–gut–brain axis. In theory, every
disease associated with the impairment of intestinal microflora might benefit from the
therapeutic modulation of the gut microbiota.
The purpose of this review is to address the most recent findings regarding probiotic regulation
of immune health. Probiotic genes and probiotic-derived factors involved in the regulation of
host immunity, molecular targets of probiotic action responsible for the host immune respons‐
es, and roles and mechanisms of probiotics in prevention and treatment of diseases [7], which
are included in clinical applications and mechanisms of action, are of special interest.
The role of specific microorganisms and the overall diversity of the microbiota in many human
diseases can be understood to a great extent owing to the rapid growth of metagenomics
strategies. Therapies focused on specific effects of different probiotics and prebiotics on the
gut microbiota [8] can be helped by the development of this knowledge.
2. Probiotics and immune health
Hippocrates (460-370 EC) stated, “All diseases begin in the gut.” Both microbial diversity and
abundance in the gut play an important role in maintaining human health. The attachment,
growth, and penetration of pathogenic microorganisms on the gut surface can essentially be
prevented by microbiota. Pathogen resistance, both by direct interaction with pathogenic
bacteria and by influencing the immune system, is influenced greatly by the intestinal
microbiota [9, 10]. Many diseases start with an initial imbalance of human resident microflora
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and the related immunobiological reactivity [11]. One key player in immune health is the gut,
a part of the body that is constantly exposed to toxins and foreign antigens, such as those from
food and microbes. According to nutrition and immune expert Meydani, “The gut is the largest
immune organ in the body, accounting for 25% of the immune cells in the body that provide
50% of the body’s immune response.” Meydani called intestinal flora “forgotten organ”
because of their vital but still underestimated health functions [12]. There are more than 400
species of bacteria residing in the gut, and they have symbiotic relationships with the body.
There are 100 trillion bacteria in our intestines. They form an ecosystem like a “flower garden”,
reported Haruji Sawada, director of the Yakult Central Institute, at the Yakult International
Nutrition and Health Conference on May 17, 2010, in Tokyo. The mammalian gut immune
system should be viewed as a complex interplay between physical, chemical, and cellular
barriers, a vast community of bacteria, and a plethora of host immune cells which mediate
innate and adaptive immunity. The intestinal microbiota helps in proper development of the
host immune system, which in turn regulates the homeostasis of the microbiota [13]. Accu‐
mulating evidence over the last decade indicates that the immune system and microbiota
interaction should be finely balanced and any perturbations of this interaction would result in
microbiota and immune dysbiosis, leading to inflammatory disorders The rapid surge in the
emerging new-age disorders such as inflammatory bowel disease (IBD), rheumatoid arthritis,
cardiovascular disease, and metabolic syndrome has driven investigators to explore their
etiology in multiple directions such as genetics, diet, and environmental factors, as well as
immune system/microbiota interactions. In addition, the practice of strict hygienic and sanitary
conditions and consumption of highly processed foods containing high fat, high carbohydrate,
and low fiber with numerous food additives and preservatives may account for altered
microbial composition, metabolism, and interaction with host immunity. Nearly all the above
diseases are characterized by local as well as systemic low-grade chronic or subclinical
inflammation in which the inflammation originated in the intestine via the interaction between
host immune system and microbiota.
Several beneficial effects of probiotics on the host intestinal mucosal defense system, including
blocking pathogenic bacterial effects by producing bactericidal substances and competing with
pathogens and toxins for adherence to the intestinal epithelium, have been identified. Probi‐
otics promote intestinal epithelial cell survival, enhance barrier function, and stimulate
protective responses from intestinal epithelial cells [14-16] in the case of intestinal epithelial
homeostasis. What matters most is that the modulation of the immune system is one of the
most reasonable mechanisms underlying the beneficial effects of probiotics on human health.
Enhancement of the innate and adaptive immunity and modulation of pathogen-induced
inflammation are the discovered effects of probiotics.
Strictly defined strains using genetic, serological, microbiological, and biochemical analyses;
lack of pathogenicity, lack of cancerogenicity, presence of beneficial factors; possibility for
colonization of the large intestine; viable cultures; acid and bile resistance; proved clinical
efficacy are among the requirements for the organisms to be used as probiotics [17].
The established probiotics that meet these criteria are generally lactic acid bacteria (LAB), most
commonly Lactobacillus and Bifidobacterium species, but also Lactococcus, Streptococcus, and
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Enterococcus species and certain yeast strains. Numerous other LAB have shown probiotic
potential in animal studies. For the treatment of IBD, several probiotics have been shown to
be efficacious: Lactobacillus casei, Lactobacillus plantarum, Lactobacillus bulgaricus, and Lactoba‐
cillus acidophilus; three strains of Bifidobacteria and S. thermophilus. In recent years, evidence has
accumulated that probiotic strains can exhibit the same activities as commensal bacteria,
including immunomodulation [5,11].
Lactic acid bacteria are present in many feeds such as yogurt and are frequently used as
probiotics to improve some biological functions of the host. Beneficial effects of the lactobacilli
on the body have been identified in the treatment or prevention of acute viral gastroenteritis,
after antibiotic-associated diarrhea, certain pediatric allergic diseases, necrotizing enterocoli‐
tis, and inflammatory bowel disease such as Crohn’s disease and postoperative hernias.
Probiotics have been long reported to aid in the treatment of many dysfunctions of the GI tract,
and the mechanisms by which probiotics work have recently been elucidated. There are
experimental and clinical data [18-24]. Probiotics are described as useful also in combating
oxidative stress, improvement in mucosal immunity [25], and general immunity [26]. The
desirable changes of the intestinal microbiota were achieved as yogurt was able to attenuate
the symptoms of acute inflammation by reducing inflammatory cytokines and increasing
regulatory cytokine IL-10-producing cells. The use of murine models demonstrated that the
consumption of fermented milks can modulate the immune system and can maintain it in a
state of surveillance, which could affront different pathologies such as cancer and intestinal
inflammation on its part.
3. Gut’s role in immune function
The contributions of the gut microbiota to the development of the immune system have been
extensively characterized. One of these characterizations suggests that the host is able to
tolerate the large amount of antigens present in the gut [27], owing to the coordinated cross
talk between the gut microbiota and the immune system.
Progress in the current knowledge on biodiversity of the intestinal microbiota allows us to
understand the mechanisms of how different microorganisms affect the function of the body
and the impact of these mechanisms. Altered microflora (dysbiosis) is generally associated
with gastrointestinal disorders, but rather a microbial imbalance is associated with common
diseases, which are not limited to the gastrointestinal tract [28, 29]. Studies in germ-free (GF)
mice give much of the evidence about how microflora forms immune system as GF mice are
completely lacking microflora. These mice show profound immune defects, such as fewer and
smaller Peyer plaques and mesenteric lymph nodes and also reduced B and T cell immune
response [30-32]. Therefore, the serum immunoglobulin (Ig) G and IgA levels in the gut GF
mice were reduced [33, 34]. Moreover, many studies in mice and humans show that certain
inflammatory diseases are associated with an altered microflora [9, 35, 36].
Inflammatory diseases are often caused by microbial dysbiosis. It was found in a prospective
study of children with a high risk of developing asthma that changes in the microbiota occur
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before the development of the disease [37]. Regulation of immune responses requires certain
species of gut commensal microbiota and perturbations in the microbiota could lead to a lack
of immune regulation, the outgrowth of more pathogenic microbes, and the promotion of
inflammation. The microbial composition of the microbiota in the adult human gut is mainly
determined by the microorganism to which the newborn child is exposed during the first years
of life. Strategies to manipulate the microbiota during infancy have been shown to prevent
development of allergic and atopic diseases later in adult life [38-40]. Thus, the use of probiotics
and prebiotics during the early postnatal period has been proposed for the intentional
modulation of the microbiota composition. In addition, diet and exposure to microbes during
pregnancy may affect the metabolic and immunological profiles of the pregnant uterus and
the risk of developing the disease in the offspring [41]. The application of probiotics and
prebiotics during pregnancy has been also proposed [42-44]. Differences in this composition
are related lo colonization; host factors, such as sex and age; genetic factors; and health state.
The dynamic state of the microbe’s ecology is increasingly being associated with an expanding
number of disorders. New high throughput methodologies such as metagenomics, transcrip‐
tomics, proteomics, and metabolomics in the post-genomic era have greatly helped the
understanding of the mechanisms, by which the microbiota contributes to host physiology in
healthy and ill individuals. Metagenomic studies of the human gut microbiota, for example,
have suggested that host metabolism is affected by low bacterial diversity, which is also related
to obesity and other diseases [45, 46J.
4. Probiotic modulation of the gastrointestinal mucosal immune system
Perhaps one of the most important aspects of probiotic bacteria is the ability to modulate the
host GIT mucosal immune system locally and systemically The interaction between the
probiotic microbe with the resident microbiota, gastrointestinal epithelia and gut immune cells
to produce an immunomodulatory response is quite complex, and has been reviewed exhaus‐
tively [34, 47- 49].
The expression of cytokines and chemokine genes was carried out by activated nuclear factor
kappa-B (NF-κB) and mitogen-activated protein kinase signalling cascades, mediated of
MAMPs, PRRS (including NOD-like receptor, Toll-like receptors, and C-type lectin receptors).
Lipoteichoic acids (DMA), peptidoglycan and S-layer proteins are mostly found MAMPs from
probiotic microorganisms. [48, 50] [Figure 1].
Multiple studies have explored the immunomodulatory effect of these MAMPs using func‐
tional genomic techniques. Various studies have demonstrated a significant reduction in
product ion of proinflammatory cytokines with a simultaneous increase in anti-inflammatory
IL-10 and the down regulation of pro-inflammatory IL-12 and TJMF-H. [23, 51J. Microflora in
the intestine promotes mucosal barrier function, and also improves the immunity of the host
to enteric infection. During the active infection a cytokine normally produced is IL-1β, which
is critical for neutrophil restoration and eradication of the pathogen. Microflora play a vital
role in the production of homeostatic levels of pro-IL-1β in local intestinal macrophages. The
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gut microbiota can also enhance host immunity through MyD88-independent mechanisms
(MyD88 – Myeloid differentiation primary response gene 88). Notably, colonization of GF mice
by commensal bacteria induces development of Th-17 cells in the intestine, which is important
for protection against Citrobacter rodentium infection [52].
5. Immune cells
Probiotics regulate host innate and adaptive immune responses by modulating the functions
of dendritic cells, macrophages, and T and B lymphocytes. Probiotics regulate immunomo‐
dulalory functions through the activation of toll-like receptors, which is one of the mechanisms
of regulation. Recent studies indicate that probiotics activate innate immunity by enhancing
adaptive immune response [20, 53]. One of the proposed mechanisms is by activation of toll-
like receptors.
Regulatory dendritic cells are the primary professional antigen presenting cells (APCs)
modulating adaptive immune responses. Probiotics containing L. acidophilus, L. casei, L. reuteri,
E. bifidium, and Streptococcus thermophilus, stimulate dendritic cells to produce IL-10, TGF-β,
COX-2, and indoleamine 2,3-dioxygenase, which in turn increase the formation of CD4 Foxp3
regulatory T cells (Tregs) and the suppressor activity of naturally occurring CD4 CD25 Tregs.
They also decrease responsiveness of T and B lymphocytes and the number of T helper (Th)
1, Th2, and Th17 cytokines without inducing apoptosis. This mixture suppressed 2,4,6-
Figure 1. Probiotic modulation of the gastrointestinal mucosal immune system. While intestinal epithelial cells (IECs)
exposed to pathogenic microbes or related stimuli produce proinflammatory mediators such as interleukin 8 (IL-8) and
tumour necrosis factor a (TNF-a), probiotics suppress the production of these cytokines and instead induce anti-in‐
flammatory mediators such as transforming growth factor b (TGF-b) and thymic stromal lymphopoietin (TSLP), which
can promote the differentiation of immature dendritic cells (iDCs) to regulatory dendritic cells (DCregs). Macrophages
in the inflamed mucosa produce high amounts of IL-6, and probiotics can decrease their IL-6 production and increase
IL-10 production.
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trinitrobenzenesulfonic acid-induced intestinal inflammation, which was associated with
enrichment of CD4 Foxp3 Tregs in the inflamed regions, as was found by in vivo studies. Thus,
probiotics that enhance the generation of regulatory dendritic cells to induce Tregs, represent
a potential therapeutic approach for inflammatory disorders [50, 54].
Nowadays, the exact mechanism of interaction between probiotic microorganisms and host
cells remains elusive. Nevertheless, there is enough gathered information that microbiota in
the gut could affect the immune response at both systemic and mucosal levels. Some putative
mechanisms include: influence of the microflora itself, amelioration of membrane barrier
function, and direct effects of probiotic microorganisms on different epithelial and immune
cell types. Many patients with inflammatory bowel disease (IBD) use probiotics to manage this
intestinal condition. Downregulation of production of proinflammatory cytokines and other
inflammatory mediators seems to constitute important mechanisms for the partial ameliora‐
tion of colitis, seen with numerous LAB strains in various models. It must also be noted that
TNF-α blocking agents are also quite successful in the treatment of patients with CD (Crohn’s
disease) [55]. However, it should be taken into account that different probiotic bacterial species
and strains have various beneficial effects and therefore need to be selected in a more rational
manner to treat human diseases.
6. Lactobacillus bulgaricus – The contribution to modern healthy nutrition
Lactobacillus bulgaricus is the only probiotic microorganism named after a certain territory and
nation. It only multiplies in the region of modern Bulgaria, coinciding with ancient Thrace. It
mutates and stops its multiplication after 1-2 fermentations in other regions of the world.
Bulgarian traditional food comprises Lactobacillus bulgaricus. Lactobacillus bulgaricus is included
in the production of Bulgarian food products based on lactic acid, such as yogurt, feta yogurt,
white brine cheese, other cheeses and cream, humanized baby food, probiotic functional foods,
and whole food supplements [56-58].
Lactobacillus bulgaricus was known to the Thracians – the ancient population that lived in what
is at present Bulgarian land, more than 7–8 thousand years ago. The word yogurt is Thracian
and means hard, solid milk. During his tour in Thrace, the Greek scientist Herodotus (484–425
BC) wrote that the Thracians prepare special fermented dairy food, which is a gift from their
Gods [59].
The father of probiotics and Nobelist – Ilya Metchnikoff (the Russian scientist) attributes the
long and healthy life of Bulgarians largely to the yogurt consumption and in particular to the
local bacterium in yogurt in his work “Prolongation of Life” [Figure 2].
In 1905 in Geneva, the Bulgarian student Stamen Grigorov isolated Lactobacillus bulgaricus from
yogurt, brought from Bulgaria [Figure 3].
BSS (Bulgarian State Standard) for yogurt was established in Bulgaria in compliance with
European standards of origin. Responding to this standard, the lactic acid fermentation should
be accomplished using only Lactobacillus bulgaricus and Streptococcus thermophilus. Yogurt is a
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fermented milk product with the typical bacterial cultures Lactobacillus bulgaricus and
Streptococcus thermophilus (the standards of identity, published in the US Code of Federal
Regulations).
In Commission Regulation (Elf) No 432/2012 in the list of the permitted health claims made on
foods, the only probiotic microorganisms included are Lactobacillus bulgaricus and Streptococcus
thermophilus. According to the claim, in doses over 108 colony forming units, they improve
lactose digestion [60].
Figure 2. Prof. I. Metchnikoff
Figure 3. Dr Stamen Grigorov
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In the 1990s, Lactobacillus bulgaricus was used in the production of probiotic functional food for
astronauts, which was tested during the flight of the second Bulgarian astronaut in Space [61],
Until recently it was considered that Lactobacillus bulgaricus can be isolated from plants –
dogwood, rose cup, etc. Bulgarian scientists, N. Alexandrov and D. Petrova have isolated
Lactobacillus bulgaricus and other fermented milk probiotic microorganisms from spring water
in Bulgaria [62, 63]. There is experimental and clinical scientific evidence from around the
world of the beneficial effects of Lactobacillus bulgaricus in stimulating the immune system,
regulating functions and microbial flora of the gastrointestinal tract, including diarrhea and
dysbacteriosis, reducing the risk of cancer, radiotherapy protecting effect, regulating choles‐
terol levels, competitive inhibition of pathogenic strains causing infections, alleviating lactose
intolerance, and anti-mutagenic effect. Lactobacillus bulgaricus has a beneficial effect on the
health of women because of its similarity to the Doederlein flora in the vagina of the woman
[64]. Lactobacillus bulgaricus, unlike other probiotic microorganisms, which secrete only L (+)
lactic acid, secretes L (+) and D (-) lactic acid during fermentation. This determines its powerful
antioxidant and anticancer effect. Lactobacillus bulgaricus produces antimicrobial substance,
known as Bulgariacan, which is resistant to heat and active against highly virulent (pathogenic)
strains of microorganisms [56, 57]. It has been shown that Lactobacillus bulgaricus adheres best
on the colonic mucosa, followed by a rapid reproduction in the body. This is crucial for its
more powerful treatment and detoxic effect than other lactic acid bacteria probiotics.
Lactobacillus bulgaricus is reproduced best with Streptococcus thermophilus. To gain rapid
biomass and biologically active substances and to potentiate their effect, joint cultivation of
Lactobacillus bulgaricus and Streptococcus thermophilus is needed. Lots of scientific studies of
yeasts, containing Lactobacillus bulgaricus and Streptococcus thermophilus, used in yogurt
production, were carried out in Bulgaria. The results show that these specific bacteria of yogurt
are stable and survive after passage through the human gastrointestinal tract.
Certain Bulgarian companies are using modern biotechnology, and wrap strains of Lactobacil‐
lus bulgaricus and other probiotic microorganisms with a natural coating, consisting of
components of the growing medium, during fermentation. This helps the production of
probiotics and the isolation of the new probiotic strains from spring water, which normally
survives under changing climatic conditions. Theses probiotic microorganisms should retain
their stability and vitality when passing through the gastrointestinal tract, as well as when
stored in shops at temperatures of up to 24o C for the entire shelf life.
Lactobacillus bulgaricus is the ancient contribution of mankind to modern science and to the
creation of the first healthy foods in the world.
7. Probiotics and probiotic functional foods – Legislation and modern
challenges
According to the World Health Organization (WHO) and the Food and Agriculture Organi‐
zation (FAO), probiotics are live microorganisms which, when administered in adequate
amounts, confer a health benefit on the host [65].
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For the last decades, there has been a rapid growth in the application of probiotics among
both people and animals.  They are used in the production of fermented products (milk,
cheese),  as  ingredients  in  adapted  milk  for  babies  and  children,  in  bakery  products  or
confectionery, or as material for the production of food additives. Another modern trend
in agricultural science is the use of probiotics in animal breeding and poultry farming to
reduce  the  disease  rates  with  young  animals,  for  maximum  utilization  of  nutrition
ingredients  of  fodder,  and  fast  accumulation  of  muscle  mass  without  treatment  with
hormonal  preparations  and  antibiotics,  as  well  as  to  increase  the  volume  of  additional
products that animals and poultry give – eggs, milk, etc.
Probiotic microorganisms belong to the Lactobacillus, Lactococcus, Bifidobacterium, Pediococcus,
or Bacillus family, with the microorganisms from Lactobacillus family being most frequently
used as probiotics.
According to Claire M. Hassler from the Illinois University, the probiotics from the Lactoba‐
cillus family are functional ingredients contained in yogurt and other dairy products, which
improve the health condition of the gastrointestinal tract. Many researches confirm the health
benefits of probiotics for maintaining gastrointestinal health, avoiding infections through
competitive suppression of the development of pathogenic strains, strengthening the immune
system, prevention against colorectal cancer, reduction of serum cholesterol, relieving
intolerance toward lactose, etc.
Probiotics have healthy effect if taken in specific quantities. According to the Japanese
scientists, N. Ishibashi and S. Shimamura, the recommended quantity of live microorganisms
in a probiotic product must be at least 107 live microorganisms per gram or per milliliter.
According to other scientists, Gomez and Vinderola, the minimum required concentration of
live cells in each gram probiotic product at the moment of consumption must be from 106 to
109 to have any favorable effect.
Today, the market offers a wide range of probiotic products and most of them are in dry forms.
A number of factors have influence on the expiry periods of dried probiotic products and their
subsequent effect when consumed. The creation of probiotic formulas with lasting durability
of the strains and longer expiry periods still continues to be a challenge. Manufacturers of
probiotic products constantly apply innovations, which aim to preserve the vitality of probiotic
strains during the drying process (lyophilization), rehydration, when passing through the
gastrointestinal tract and the strongly alternating pH in the stomach and biliary salts, and
during their storage in the sales points. There are numerous researches of the molecular
characteristics of probiotic strains and their health effects.
Companies apply different approaches to create new probiotic formulas with preserved
vitality of the strains and useful effects. Some Korean and Japanese companies divide probiotic
products into four generations:
• First generation – probiotic microorganisms without coating
• Second generation – probiotic microorganisms with single synthetic coating, which protects
them when passing through the gastrointestinal tract
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• Third generation – microcapsuled probiotic microorganisms with synthetic capsule
• Fourth generation – probiotic microorganisms with two synthetic coatings, protein and
mucopolysaccharides, which protect them when passing through the gastrointestinal tract
and against high pressure and temperature
Some scientists apply genetic manipulation of known strains to increase their durability.
American companies test possible probiotic effects of known spore-carrying microorganisms
from the Bacillus family.
Bulgarian manufacturers of probiotics coat the strains of lactic acid microorganisms with
natural coating, which consist of ingredients of the food media aiming to raise their durability
with the alternating pH and temperature. The Bulgarian scientist, Nikola Alexandrov and his
fellow researchers, isolated for the first time in the world 8 completely natural probiotic strains
from the Lactobacillus family from pure spring water in Bulgaria [62,63] [Figure 4].
Figure 4. Probiotics from spring water
Research in this field will have major importance for the manufacturers of probiotics, who
want to achieve longer term of durability and better health effect of their probiotic products.
These researches are also extremely important for the end consumers who demand high-
quality functional products to improve the quality of their life.
8. Probiotic functional foods
The oldest concept of functional foods was created by the father of medicine – Hippocrates.
He wrote, “Let food be your medicine and medicine – your food.”
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Food’s major role is to provide sufficient nutritive substances, which will satisfy the need for
food of the human organism. Today, nutrition science faces new challenges far beyond the
concept of food insufficiency.
There are both socioeconomic changes taking place in the world and changes in the demo‐
graphic structure of population – growing number of elderly people and increase of the
expenses for healthcare. Therefore, governments, researchers, health experts, and the foodstuff
industry, in general, direct their efforts to identification and creation of functional foods, which
may improve the health of the local population, reduce the risk of diseases with social impact,
such as cardiovascular diseases, cancer, osteoporosis, and improve the quality of life for the
people. In combination with healthy living, the daily use of these functional foods may have
positive impact for the health of both working people in active age and their families and for
the elderly. This will result in the sharp reduction of the expenses for healthcare and in the
optimization of physical and mental health of the population.
Nowadays scientific evidences proved that some foods and food ingredients have favorable
physiological and psychological effects beyond the supply with major food substances.
Modern researches focus on the identification of the biologically active components in food,
which maintain human health and reduce the risk of diseases. It has been found that many
traditional foodstuffs, such as eggs, milk, whole-wheat food, fruits, vegetables, soya, etc.
contain components of potential benefit for health. Apart from these foods, there are new
products that have been developed to increase or combine these useful components because
of their benefits or desired physiological effects.
Functional foods are foods that are consumed as part of the normal nutrition process. They
have useful effects when consumed in normal quantities within the dietary regime. Functional
food could be:
• Food of natural origin – unskimmed milk, whole-wheat bread, etc.
• Food technologically or biotechnologically enriched with some ingredient
• Food from which ingredient has been extracted technologically or biotechnologically
• Food, in which the nature of one or more substances has been modified
• Food, in which bioavailability of one or more substances has been modified
• Food, which is a combination of two or more of the foods described above
Functional food may be addressed to the overall population or separate groups identified in
terms of age (e.g., children or adults), genetic and enzyme modifications (intolerance toward
gluten, lactose intolerance), functional status (pregnancy, for example), etc. Functional foods
must be in conformity with the overall significance of nutrition – potential interrelations with
other food substances and ingredients or possible undesired effects, including allergies and
intolerance.
The foundations of the modern science of functional foods were laid in Japan during the 1980.
The concept of food of specific health use (FOSHU) was established in 1991. Foods defined as
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FOSHU are approved by the Minister of Health and Social Cares of Japan after providing
detailed and sufficient scientific evidence. Such foods are consumed as part of the standard
diet [66]. In USA, the requirements for “reduction of the risk of diseases” for specific foods
were made binding by law in 1993. The opinions and conclusions related to health are subject
to approval by the Food and Drugs Agency on the base of scientific evidence and their goal is
to help consumers by providing information about healthy nutrition, thus avoiding the risk
of diseases [67]. In the European Union, the development and the approval of functional foods
is regulated by a special organization to the European Commission known as FUFOSE
(Functional Food Science in Europe) in cooperation with the European ILSI (International Life
Science Institute), which works mainly on issues referring to the harmonization of the
legislation in the field of functional foods in the EU Member States. This European Commission
has developed two types of health requirements for functional foods: “increased function” and
“reduction of the risk of disease” [60]. In Bulgaria, the permit for the production of food with
special designation is given by the Bulgarian Food Safety Agency (BFSA) after provision of
scientific evidence to the Ministry of Health of the Republic of Bulgaria [63, 67].
The biggest challenge before the scientists in the field of nutrition now and in the future is to
research the interrelations between a given food or food ingredient and the improved health
and reduced risk of various diseases. The provision of accessible and detailed information for
the qualities of the functional foods is of exceptional importance for the consumers’ choice of
food.
9. Conclusion and future directions
Probiotics are reliable resources for prevention and treatment of immune disorders. There are
a lot of encouraging data based on analyses of studies in humans and animal models that
probiotics possess clinical efficacy in ulcerative colitis and irritable bowel syndrome as well as
other intestinal diseases such as infectious diarrhea, antibiotic-associated diarrhea, necrotizing
enterocolitis. The most recent studies suggest the exciting possibility that probiotics can be
modified for delivery of vaccines and to potentiate the effects of vaccination [68]. While the
paradigm of discovery-based genomics in probiotic LAB has uncovered vital aspects of
probiotic mechanisms, it has also revealed the complexity of these interactions with the
resident microbiota and the mucosal immune system. Nevertheless, a great opportunity was
revealed by this challenge. For example, probiotic bacteria are now being explored as suitable
models for vaccine/drug production, due to their close association with host immunity and
immunomodulatory action [45, 69]. Latest discoveries show that the role of probiotic bacteria
and the resident microbiota extend far beyond gastrointestinal health. It has revealed neuro‐
chemical importance of intestinal homeostasis. There are studies that show cross talk between
gastrointestinal tract and brain (brain–gut axis) [70]. Along with these advancements, it is
important that human clinical trials continue with experimental designs that are well-
controlled and well-defined, reflecting the great progress that has been made in the field of
probiotic and GIT microbiome research [71]. With more than a century passing since Metch‐
nikoff’s observations, keen experimental design using integrated genomics has led to a clearer
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definition of probiotic bacteria, as well as a model for continued discovery. Bulgaria becomes
famous in the world with Lactobacillus bulgaricus and the Bulgarian territory is still an important
reservoir for isolation of natural strains of lactic acid bacteria, which after an additional
selection are used as starter cultures for the production of various fermented foods and
probiotic products. The biggest challenge for researchers in the field of nutrition, at present
and in the future, is the study of the relationship between a certain food or a nutrient and
improved health or reduced risk of various diseases. Provision of accessible and comprehen‐
sive information about the properties of functional foods is crucial for food selection by
consumers.
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